No takes yet. Share an insight, caveat, or question.
Preclinical study shows intranasal stem cell vesicles curb neuroinflammation and amyloid burden in Alzheimer's mice, indicating therapeutic potential as a disease-modifying biologic.
Madhu et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: